You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 63 Issue 3

March 2007

Volume 63, Issue 3

Pages 255–382

  1. Editors' view

    1. Top of page
    2. Editors' view
    3. Review
    4. Editorial commentary
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Paediatric pharmacokinetics
    8. Pharmacogenetics
    9. Interactions
    10. Therapeutics
    11. Short reports
    12. Letters to the Editors
    1. You have free access to this content
  2. Review

    1. Top of page
    2. Editors' view
    3. Review
    4. Editorial commentary
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Paediatric pharmacokinetics
    8. Pharmacogenetics
    9. Interactions
    10. Therapeutics
    11. Short reports
    12. Letters to the Editors
    1. You have free access to this content
  3. Editorial commentary

    1. Top of page
    2. Editors' view
    3. Review
    4. Editorial commentary
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Paediatric pharmacokinetics
    8. Pharmacogenetics
    9. Interactions
    10. Therapeutics
    11. Short reports
    12. Letters to the Editors
    1. You have free access to this content
  4. Pharmacodynamics

    1. Top of page
    2. Editors' view
    3. Review
    4. Editorial commentary
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Paediatric pharmacokinetics
    8. Pharmacogenetics
    9. Interactions
    10. Therapeutics
    11. Short reports
    12. Letters to the Editors
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Adrenal axis suppression unrelated to the dynamics of dosing with beclomethasone monopropionate (pages 288–291)

      Siobhan A. Mulrennan, Joseph S. Hogg, Richard C. Teoh and Alyn H. Morice

      Version of Record online: 19 SEP 2006 | DOI: 10.1111/j.1365-2125.2006.02765.x

  5. Pharmacokinetics

    1. Top of page
    2. Editors' view
    3. Review
    4. Editorial commentary
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Paediatric pharmacokinetics
    8. Pharmacogenetics
    9. Interactions
    10. Therapeutics
    11. Short reports
    12. Letters to the Editors
    1. You have free access to this content
    2. You have free access to this content
      Population pharmacokinetics of darbepoetin alfa in haemodialysis and peritoneal dialysis patients after intravenous administration (pages 300–309)

      Hirotaka Takama, Hideji Tanaka, Daisuke Nakashima, Hiroyasu Ogata, Eiji Uchida, Tadao Akizawa and Shozo Koshikawa

      Version of Record online: 31 AUG 2006 | DOI: 10.1111/j.1365-2125.2006.02756.x

    3. You have free access to this content
      Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects (pages 310–314)

      Clark Chan, Kwee P. Yeo, Alan X. Pan, Maggie Lim, Mary P. Knadler and David S. Small

      Version of Record online: 12 SEP 2006 | DOI: 10.1111/j.1365-2125.2006.02770.x

  6. Paediatric pharmacokinetics

    1. Top of page
    2. Editors' view
    3. Review
    4. Editorial commentary
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Paediatric pharmacokinetics
    8. Pharmacogenetics
    9. Interactions
    10. Therapeutics
    11. Short reports
    12. Letters to the Editors
    1. You have free access to this content
      Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma (pages 315–321)

      Sreeja Sudhakaran, Craig R. Rayner, Jian Li, David C. M. Kong, Neil M. Gude and Roger L. Nation

      Version of Record online: 19 SEP 2006 | DOI: 10.1111/j.1365-2125.2006.02766.x

    2. You have free access to this content
      Transfer of the antidepressant mirtazapine into breast milk (pages 322–327)

      J. H. Kristensen, Kenneth F. Ilett, 1,2 Jonathan Rampono, 3 Rolland Kohan and 4 L. Peter Hackett 2

      Version of Record online: 13 SEP 2006 | DOI: 10.1111/j.1365-2125.2006.02773.x

  7. Pharmacogenetics

    1. Top of page
    2. Editors' view
    3. Review
    4. Editorial commentary
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Paediatric pharmacokinetics
    8. Pharmacogenetics
    9. Interactions
    10. Therapeutics
    11. Short reports
    12. Letters to the Editors
    1. You have free access to this content
  8. Interactions

    1. Top of page
    2. Editors' view
    3. Review
    4. Editorial commentary
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Paediatric pharmacokinetics
    8. Pharmacogenetics
    9. Interactions
    10. Therapeutics
    11. Short reports
    12. Letters to the Editors
    1. You have free access to this content
    2. You have free access to this content
  9. Therapeutics

    1. Top of page
    2. Editors' view
    3. Review
    4. Editorial commentary
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Paediatric pharmacokinetics
    8. Pharmacogenetics
    9. Interactions
    10. Therapeutics
    11. Short reports
    12. Letters to the Editors
    1. You have free access to this content
      Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage (pages 346–355)

      Elisabetta Poluzzi, Petar Strahinja, Alberto Vaccheri, Antonio Vargiu, Maria Chiara Silvani, Domenico Motola, Giulio Marchesini, Fabrizio De Ponti and Nicola Montanaro

      Version of Record online: 10 NOV 2006 | DOI: 10.1111/j.1365-2125.2006.02801.x

    2. You have free access to this content
      Effectiveness of β-blocker therapy in daily practice patients with advanced chronic heart failure; is there an effect-modification by age? (pages 356–364)

      Daniela Dobre, Mike J. L. DeJongste, Carolien Lucas, Ger Cleuren, Dirk J. Van Veldhuisen, Adelita V. Ranchor and Flora Haaijer-Ruskamp

      Version of Record online: 12 SEP 2006 | DOI: 10.1111/j.1365-2125.2006.02769.x

  10. Short reports

    1. Top of page
    2. Editors' view
    3. Review
    4. Editorial commentary
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Paediatric pharmacokinetics
    8. Pharmacogenetics
    9. Interactions
    10. Therapeutics
    11. Short reports
    12. Letters to the Editors
    1. You have full text access to this OnlineOpen article
      Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjects (pages 365–370)

      Nassr Nassr, Gezim Lahu, Oliver Von Richter, Felix Reutter, Dietrich Knoerzer, Karl Zech, Katharina A. Erb, Barbara Schug, Henning Blume and Robert Hermann

      Version of Record online: 29 SEP 2006 | DOI: 10.1111/j.1365-2125.2006.02762.x

    2. You have free access to this content
      Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder (pages 371–375)

      Kenneth F. Ilett, L. Peter Hackett, Judith H. Kristensen and Rolland Kohan

      Version of Record online: 12 SEP 2006 | DOI: 10.1111/j.1365-2125.2006.02767.x

    3. You have free access to this content
      Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol (pages 376–379)

      Ciro Costagliola, Claudio Campa, Francesco Parmeggiani, Carlo Incorvaia, Paolo Perri, Sergio D’Angelo, Giuseppe Lamberti and Adolfo Sebastiani

      Version of Record online: 19 SEP 2006 | DOI: 10.1111/j.1365-2125.2006.02768.x

  11. Letters to the Editors

    1. Top of page
    2. Editors' view
    3. Review
    4. Editorial commentary
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Paediatric pharmacokinetics
    8. Pharmacogenetics
    9. Interactions
    10. Therapeutics
    11. Short reports
    12. Letters to the Editors
    1. You have free access to this content
    2. You have free access to this content

SEARCH

SEARCH BY CITATION